OMG, stop it. AbbVie is out here acting like SKYRIZI® is the new crush everyone’s talking about. Like, it got a positive nod from Canada’s Drug Agency for ulcerative colitis AND Crohn’s disease? Okay, cool, but also, slow down. It’s just medicine, not a rom-com hero.
I swear, ABBV is trying so hard to be the popular kid in healthcare. They got this “letter of intent” thing with the pan-Canadian Pharmaceutical Alliance, which sounds fancy but really means they’re just flirting with approval. It’s like that ex who texts you 3 AM but doesn’t commit. Ugh, commitment issues much?
And those trial names? MOTIVATE, ADVANCE, FORTIFY… they sound like workouts, not science! I can’t decide if they’re trying to fix my gut or my gym routine. Plus, INSPIRE and COMMAND? Is this a drug or a Marvel squad? I’m confused but also kinda entertained.
Anyway, if you thought healthcare was boring, nope. It’s a messy soap opera with ABBV playing the lead, desperately wanting to be everyone’s fave. Meanwhile, I’m just here sipping my tea, watching the drama unfold like it’s my favorite reality show.
Want more chaos from the market’s latest freakouts? Check out the tech meltdown or the financial mess because why settle for one disaster when you can get a whole season?
Think you’re wired for chaos? Tap here.